Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($8,806.0M) | ($2,724.0M) | ($739.0M) | ($7,608.0M) | ($3,592.0M) | ($8,409.0M) | $14.8B | $8,629.0M | $3,014.0M | $8,693.0M | $6,497.0M | $18.8B | $18.3B | $18.9B | $16.1B | $17.9B | $26.5B | $2,764.0M | $9,034.0M | $12.4B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Novartis AG's last 12-month Net Debt is $18.1B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Novartis AG's Net Debt growth was 45.2%. The average annual Net Debt growth rates for Novartis AG have been (18.7%) over the past three years, (3.3%) over the past five years.
Over the last year, Novartis AG's Net Debt growth was 45.2%, which is higher than industry growth of 0.3%. It indicates that Novartis AG's Net Debt growth is Bad.